rs775186117
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001267550.2(TTN):c.47692C>T(p.Arg15898*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000209 in 1,437,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R15898R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001267550.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001267550.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TTN | NM_001267550.2 | MANE Select | c.47692C>T | p.Arg15898* | stop_gained | Exon 254 of 363 | NP_001254479.2 | ||
| TTN | NM_001256850.1 | c.42769C>T | p.Arg14257* | stop_gained | Exon 204 of 313 | NP_001243779.1 | |||
| TTN | NM_133378.4 | c.39988C>T | p.Arg13330* | stop_gained | Exon 203 of 312 | NP_596869.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TTN | ENST00000589042.5 | TSL:5 MANE Select | c.47692C>T | p.Arg15898* | stop_gained | Exon 254 of 363 | ENSP00000467141.1 | ||
| TTN | ENST00000446966.2 | TSL:1 | c.47536C>T | p.Arg15846* | stop_gained | Exon 252 of 361 | ENSP00000408004.2 | ||
| TTN | ENST00000436599.2 | TSL:1 | c.47416C>T | p.Arg15806* | stop_gained | Exon 252 of 361 | ENSP00000405517.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000459 AC: 1AN: 217976 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000209 AC: 3AN: 1437602Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 713518 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 1G Pathogenic:2
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg15898*) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with dilated cardiomyopathy (PMID: 25589632, 29961767). ClinVar contains an entry for this variant (Variation ID: 223371). This variant is located in the A band of TTN (PMID: 25589632). Truncating variants in this region are significantly overrepresented in patients affected with dilated cardiomyopathy (PMID: 25589632). Truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
not provided Pathogenic:1
Primary dilated cardiomyopathy Pathogenic:1
This TTN truncating variant (TTNtv) was identified in one individual in this cohort and is located in an exon that is highly expressed in the heart. In the seven cohorts assessed, TTNtv were found in 14% of ambulant DCM, 22% end-stage or familial DCM, and 2% controls. Heterozygous nonsense, frameshift and canonical splice-disrupting variants found in constitutive and other highly utilised exons are highly likely to be pathogenic when identified in individuals with phenotypically confirmed DCM. TTNtv found incidentally in healthy individuals (excluding familial assessment of DCM relatives) are thought to have low penetrance, particularly when identified in exons that are not constitutively expressed in the heart.
Cardiovascular phenotype Pathogenic:1
The c.20497C>T (p.R6833*) alteration, located in exon 82 (coding exon 81) of the TTN gene, consists of a C to T substitution at nucleotide position 20497. This changes the amino acid from a arginine (R) to a stop codon at amino acid position 6833. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. The TTN c.20497C>T alteration failed random forest filters in the Genome Aggregation Database (gnomAD). This variant (also referred to as NM_001267550.1:c.47692C>T, p.R15898*) was reported in an individual with features consistent with dilated cardiomyopathy (Roberts, 2015; Minoche, 2019). This exon is located in the A-band region of the N2-B isoform of the titin protein and is constitutively expressed in TTN transcripts (percent spliced in or PSI 100%). Based on the available evidence, this alteration is classified as likely pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at